Photos
There are no current photos
Testimonies

"I strongly believe in what OTRADI was designed to do, and that is bring together four Oregon research institutions and capitalize on their complementary strengths. It's a way of facilitating collaboration and adds a significant capability we didn't have before, and that is a high-throughput screening facility that allows us to rapidly identify and evaluate potential new leads for drugs. It adds a truly competitive edge to research and development facilities in Oregon." - Kevin A. Reynolds, Ph.D., professor and chair of PSU's chemistry department

"We have had no way in Oregon, prior to OTRADI, to analyze and effectively screen for infectious diseases and look at the compounds we've developed to find out if they were worthwhile. I don't think any of us realized there would be such good results, so quickly. To be able to do that is a great boon for the research institutions of Oregon." — Michael M. Haley, UO chemistry professor

"It costs about a billion dollars to develop a new drug for use in humans, and since tropical diseases tend to occur in more impoverished countries, there's little hope that a pharmaceutical company will recoup that billion dollars. Since there are no pharmaceutical firms interested in developing a new malaria drug, the responsibility falls on academic and medical institutions to develop those therapies. OTRADI allows us to function as a far larger entity, rather than a small, academic-type lab with restricted resources. I hope that one day soon we will have novel anti-malarial treatment that can be used in those individuals who are most at risk of dying from the disease, pregnant women and young children." — Michael Riscoe, Ph.D., director of the Experimental Chemotherapy Lab at the Portland VA Medical Center

"That is truly a level of expertise that we have and it makes us more of a lightning rod for other researchers or companies that might want to move here. I think this type of technology makes us more competitive from an academic standpoint as well. It brings the required technology here and will help Oregon continue as a leader in neuroscience, infectious diseases, and cancer biology." — Mary Stenzel-Poore, Ph.D., professor and interim chair of Molecular Microbiology and Immunology at OHSU

Videos
There are no current videos